Publication | Closed Access
Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitors
32
Citations
33
References
2020
Year
OncologyNovel TherapyMedicineReceptor Tyrosine KinaseEgfr Kinase InhibitorsEgfr-mutant NsclcsPathologyComprehensive CharacterizationMolecular DiagnosticsRadiation OncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1